The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-methyl-1-(4-nitrophenethylsulfonyl)-4,5-dihydro-1H-pyrazol-5-yl)phenol ID: ALA1770495
PubChem CID: 54584754
Max Phase: Preclinical
Molecular Formula: C18H19N3O5S
Molecular Weight: 389.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC1=NN(S(=O)(=O)CCc2ccc([N+](=O)[O-])cc2)C(c2ccccc2O)C1
Standard InChI: InChI=1S/C18H19N3O5S/c1-13-12-17(16-4-2-3-5-18(16)22)20(19-13)27(25,26)11-10-14-6-8-15(9-7-14)21(23)24/h2-9,17,22H,10-12H2,1H3
Standard InChI Key: HMSFBHVDDUACRP-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
15.0428 -11.5229 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.2983 -12.3073 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8499 -11.6938 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6819 -10.7916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6807 -11.6190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3956 -12.0319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1120 -11.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1091 -10.7880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3938 -10.3789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9673 -10.3793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8808 -9.5596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0738 -9.3883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6615 -10.1029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2137 -10.7158 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7381 -8.6347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3913 -9.5539 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2583 -11.7784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0929 -12.5836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3100 -12.8439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6970 -12.2935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9148 -12.5532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7481 -13.3621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3699 -13.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1498 -13.6482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9621 -13.6262 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7972 -14.4346 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.3446 -13.0792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13 14 1 0
14 10 1 0
7 8 1 0
12 15 1 0
14 1 1 0
4 5 2 0
9 16 1 0
8 9 2 0
1 17 1 0
9 4 1 0
18 17 1 0
1 3 2 0
18 19 1 0
4 10 1 0
19 20 2 0
10 11 1 0
20 21 1 0
5 6 1 0
21 22 2 0
22 23 1 0
6 7 2 0
23 24 2 0
24 19 1 0
2 1 2 0
11 12 1 0
12 13 2 0
25 26 2 0
25 27 1 0
22 25 1 0
M CHG 2 25 1 27 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 389.43Molecular Weight (Monoisotopic): 389.1045AlogP: 3.00#Rotatable Bonds: 6Polar Surface Area: 113.11Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.16CX Basic pKa: ┄CX LogP: 2.77CX LogD: 2.77Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.60Np Likeness Score: -0.81
References 1. Liu XH, Ruan BF, Liu JX, Song BA, Jing LH, Li J, Yang Y, Zhu HL, Qi XB.. (2011) Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents., 21 (10): [PMID:21486698 ] [10.1016/j.bmcl.2011.03.066 ]